Induction of Staphylococcus aureus-specific IgA and agglutination potency in milk of cows by mucosal immunization

Vaccine

Volumn 27, Issue 30, 2009, Pages 4001-4009

  Tempelmans Plat Sinnige, Marjan J ^a,b   Verkaik, Nelianne J ^a   van Wamel, Willem J B ^a   de Groot, Nanda ^b   Acton, Dennis S ^b   van Belkum, Alex ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b Mucovax BV   (Netherlands)

Author keywords

IgA; Immune response; Staphylococcus aureus

Indexed keywords

ENTEROTOXIN; IMMUNE MODULATING PROTEIN; IMMUNOGLOBULIN A; MICROBIAL SURFACE COMPONENT RECOGNIZING ADHESIVE MATRIX MOLECULE; POLYCLONAL ANTIBODY; UNCLASSIFIED DRUG; VIRULENCE FACTOR;

ANIMAL EXPERIMENT; ANTIBODY TITER; ANTIGEN ANTIBODY REACTION; ARTICLE; BACTERIAL CELL WALL; BACTERIAL STRAIN; CONTROLLED STUDY; DAIRY CATTLE; DRUG POTENCY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMORAL IMMUNITY; IMMUNIZATION; IMMUNOGLOBULIN PRODUCTION; LACTATION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MILK; MILK LEVEL; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; SUPERNATANT; WESTERN BLOTTING; WHEY;

AGED; AGGLUTINATION; ANIMALS; ANTIBODIES, BACTERIAL; CATTLE; CHILD; HUMANS; IMMUNOGLOBULIN A, SECRETORY; MILK; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCAL VACCINES; STAPHYLOCOCCUS AUREUS;

EID: 67349096342     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.04.034     Document Type: Article

References (51)

1. Wertheim H.F., Melles D.C., Vos M.C., van Leeuwen W., van Belkum A., Verbrugh H.A., et al. The role of nasal carriage in Staphylococcus aureus infections. Lancet Infect Dis 5 12 (2005) 751-762
2. Barkema H.W., Schukken Y.H., and Zadoks R.N. Invited Review: the role of cow, pathogen, and treatment regimen in the therapeutic success of bovine Staphylococcus aureus mastitis. J Dairy Sci 89 6 (2006) 1877-1895
3. Acton D.S., Tempelmans Plat-Sinnige M.J., van Wamel W., de Groot N., and van Belkum A. Intestinal carriage of Staphylococcus aureus: how does its frequency compare with that of nasal carriage and what is its clinical impact?. Eur J Clin Microbiol Infect Dis 28 2 (2009) 115-127
4. Boyce J.M., Havill N.L., and Maria B. Frequency and possible infection control implications of gastrointestinal colonization with methicillin-resistant Staphylococcus aureus. J Clin Microbiol 43 12 (2005) 5992-5995
5. Kluytmans J.A., and Wertheim H.F. Nasal carriage of Staphylococcus aureus and prevention of nosocomial infections. Infection 33 1 (2005) 3-8
6. Zetola N., Francis J.S., Nuermberger E.L., and Bishai W.R. Community-acquired meticillin-resistant Staphylococcus aureus: an emerging threat. Lancet Infect Dis 5 5 (2005) 275-286
7. Shinefield H.R., and Black S. Prospects for active and passive immunization against Staphylococcus aureus. Pediatr Infect Dis J 25 2 (2006) 167-168
8. Woof J.M., and Kerr M.A. IgA function-variations on a theme. Immunology 113 2 (2004) 175-177
9. Weisman L.E. Antibody for the prevention of neonatal nosocomial staphylococcal infection: a review of the literature. Arch Pediatr 14 Suppl 1 (2007) S31-S34
10. Kelly J. Immunotherapy against antibiotic-resistant bacteria: the Russian experience with an antistaphylococcal hyperimmune plasma and immunoglobulin. Microbes Infect 2 11 (2000) 1383-1392
11. Baker M. Anti-infective antibodies: finding the path forward. Nat Biotechnol 24 12 (2006) 1491-1493
12. Hammarstrom L., and Weiner C.K. Targeted antibodies in dairy-based products. Adv Exp Med Biol 606 (2008) 321-343
13. Korhonen H., Marnila P., and Gill H.S. Bovine milk antibodies for health. Br J Nutr 84 Suppl 1 (2000) S135-S146
14. Pant N., Marcotte H., Brussow H., Svensson L., and Hammarstrom L. Effective prophylaxis against rotavirus diarrhea using a combination of Lactobacillus rhamnosus GG and antibodies. BMC Microbiol 7 (2007) 86
15. Tollemar J., Gross N., Dolgiras N., Jarstrand C., Ringden O., and Hammarstrom L. Fungal prophylaxis by reduction of fungal colonization by oral administration of bovine anti-Candida antibodies in bone marrow transplant recipients. Bone Marrow Transplant 23 3 (1999) 283-290
16. van Dissel J.T., de Groot N., Hensgens C.M., Numan S., Kuijper E.J., Veldkamp P., et al. Bovine antibody-enriched whey to aid in the prevention of a relapse of Clostridium difficile-associated diarrhoea: preclinical and preliminary clinical data. J Med Microbiol 54 Pt 2 (2005) 197-205
17. Numan S.C., Veldkamp P., Kuijper E.J., van den Berg R.J., and van Dissel J.T. Clostridium difficile-associated diarrhoea: bovine anti-Clostridium difficile whey protein to help aid the prevention of relapses. Gut 56 6 (2007) 888-889
18. Hanson L.A., and Korotkova M. The role of breastfeeding in prevention of neonatal infection. Semin Neonatol 7 4 (2002) 275-281
19. Woof J.M., and Kerr M.A. The function of immunoglobulin A in immunity. J Pathol 208 2 (2006) 270-282
20. van Belkum A., Melles D.C., Snijders S.V., van Leeuwen W.B., Wertheim H.F., Nouwen J.L., et al. Clonal distribution and differential occurrence of the enterotoxin gene cluster, egc, in carriage- versus bacteremia-associated isolates of Staphylococcus aureus. J Clin Microbiol 44 4 (2006) 1555-1557
21. van Leeuwen W., van Nieuwenhuizen W., Gijzen C., Verbrugh H., and van Belkum A. Population studies of methicillin-resistant and -sensitive Staphylococcus aureus strains reveal a lack of variability in the agrD gene, encoding a staphylococcal autoinducer peptide. J Bacteriol 182 20 (2000) 5721-5729
22. van Leeuwen W.B., Melles D.C., Alaidan A., Al-Ahdal M., Boelens H.A., Snijders S.V., et al. Host- and tissue-specific pathogenic traits of Staphylococcus aureus. J Bacteriol 187 13 (2005) 4584-4591
23. Melles DC, Schouls L, Francois P, Herzig S, Verbrugh HA, van Belkum A, et al. High-throughput typing of Staphylococcus aureus by amplified fragment length polymorphism (AFLP) or multi-locus variable number of tandem repeat analysis (MLVA) reveals consistent strain relatedness. Eur J Clin Microbiol Infect Dis [in press].
24. Melles D.C., Gorkink R.F., Boelens H.A., Snijders S.V., Peeters J.K., Moorhouse M.J., et al. Natural population dynamics and expansion of pathogenic clones of Staphylococcus aureus. J Clin Invest 114 12 (2004) 1732-1740
25. Vasbinder A.J., and de Kruif C.G. Casein-whey protein interactions in heated milk: the influence of pH. Int Dairy J 13 (2003) 669-677
26. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 5259 (1970) 680-685
27. Novick R.P. Analysis by transduction of mutations affecting penicillinase formation in Staphylococcus aureus. J Gen Microbiol 33 (1963) 121-136
28. Shafer W.M., and Iandolo J.J. Genetics of staphylococcal enterotoxin B in methicillin-resistant isolates of Staphylococcus aureus. Infect Immun 25 3 (1979) 902-911
29. Dubin D.T., Chikramane S.G., Inglis B., Matthews P.R., and Stewart P.R. Physical mapping of the mec region of an Australian methicillin-resistant Staphylococcus aureus lineage and a closely related American strain. J Gen Microbiol 138 3 (1992) 657
30. Oliveira D.C., Tomasz A., and de Lencastre H. The evolution of pandemic clones of methicillin-resistant Staphylococcus aureus: identification of two ancestral genetic backgrounds and the associated mec elements. Microb Drug Resist 7 4 (2001) 349-361
31. Baba T., Takeuchi F., Kuroda M., Yuzawa H., Aoki K., Oguchi A., et al. Genome and virulence determinants of high virulence community-acquired MRSA. Lancet 359 9320 (2002) 1819-1827
32. Ito T., Ma X.X., Takeuchi F., Okuma K., Yuzawa H., and Hiramatsu K. Novel type V staphylococcal cassette chromosome mec driven by a novel cassette chromosome recombinase, ccrC. Antimicrob Agents Chemother 48 7 (2004) 2637-2651
33. Oliveira D.C., and de Lencastre H. Multiplex PCR strategy for rapid identification of structural types and variants of the mec element in methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 46 7 (2002) 2155-2161
34. Milheirico C., Oliveira D.C., and de Lencastre H. Update to the multiplex PCR strategy for assignment of mec element types in Staphylococcus aureus. Antimicrob Agents Chemother 51 9 (2007) 3374-3377
35. Yu H., Nakano Y., Yamashita Y., Oho T., and Koga T. Effects of antibodies against cell surface protein antigen PAc-glucosyltransferase fusion proteins on glucan synthesis and cell adhesion of Streptococcus mutans. Infect Immun 65 6 (1997) 2292-2298
36. Roche F.M., Massey R., Peacock S.J., Day N.P., Visai L., Speziale P., et al. Characterization of novel LPXTG-containing proteins of Staphylococcus aureus identified from genome sequences. Microbiology 149 Pt 3 (2003) 643-654
37. Verkaik N.J., de Vogel C.P., Boelens H.A., Grumann D., Hoogenboezem T., Vink C., et al. Antistaphylococcal humoral immune response in nasal persistent and non-carriers of Staphylococcus aureus. J Infect Dis 199 (2009) 625-632
38. Thomas D., Chou S., Dauwalder O., and Lina G. Diversity in Staphylococcus aureus enterotoxins. Chem Immunol Allergy 93 (2007) 24-41
39. Holtfreter S., and Broker B.M. Staphylococcal superantigens: do they play a role in sepsis?. Arch Immunol Ther Exp (Warsz) 53 1 (2005) 13-27
40. Holtfreter S., Roschack K., Eichler P., Eske K., Holtfreter B., Kohler C., et al. Staphylococcus aureus carriers neutralize superantigens by antibodies specific for their colonizing strain: a potential explanation for their improved prognosis in severe sepsis. J Infect Dis 193 9 (2006) 1275-1278
41. Rooijakkers S.H., Ruyken M., Roos A., Daha M.R., Presanis J.S., Sim R.B., et al. Immune evasion by a staphylococcal complement inhibitor that acts on C3 convertases. Nat Immunol 6 9 (2005) 920-927
42. Rooijakkers S.H., van Kessel K.P., and van Strijp J.A. Staphylococcal innate immune evasion. Trends Microbiol 13 12 (2005) 596-601
43. Watts A., Ke D., Wang Q., Pillay A., Nicholson-Weller A., and Lee J.C. Staphylococcus aureus strains that express serotype 5 or serotype 8 capsular polysaccharides differ in virulence. Infect Immun 73 6 (2005) 3502-3511
44. Wang J.E., Dahle M.K., McDonald M., Foster S.J., Aasen A.O., and Thiemermann C. Peptidoglycan and lipoteichoic acid in gram-positive bacterial sepsis: receptors, signal transduction, biological effects, and synergism. Shock 20 5 (2003) 402-414
45. Morton H.C., Pleass R.J., Storset A.K., Brandtzaeg P., and Woof J.M. Cloning and characterization of equine CD89 and identification of the CD89 gene in chimpanzees and rhesus macaques. Immunology 115 1 (2005) 74-84
46. Rooijakkers S.H., Ruyken M., van Roon J., van Kessel K.P., van Strijp J.A., and van Wamel W.J. Early expression of SCIN and CHIPS drives instant immune evasion by Staphylococcus aureus. Cell Microbiol 8 8 (2006) 1282-1293
47. Lee J.C., Park J.S., Shepherd S.E., Carey V., and Fattom A. Protective efficacy of antibodies to the Staphylococcus aureus type 5 capsular polysaccharide in a modified model of endocarditis in rats. Infect Immun 65 10 (1997) 4146-4151
48. Flock J.I. Extracellular-matrix-binding proteins as targets for the prevention of Staphylococcus aureus infections. Mol Med Today 5 12 (1999) 532-537
49. Tuchscherr L.P., Buzzola F.R., Alvarez L.P., Lee J.C., and Sordelli D.O. Antibodies to Capsular Polysaccharide and Clumping Factor A Prevent Mastitis and the Emergence of Unencapsulated and Small-Colony Variants of Staphylococcus aureus in Mice. Infect Immun 76 12 (2008) 5738-5744
50. LeClaire R.D., Hunt R.E., and Bavari S. Protection against bacterial superantigen staphylococcal enterotoxin B by passive vaccination. Infect Immun 70 5 (2002) 2278-2281
51. Roitt I.M., Brostoff J., and Male D.K. Immunology (1985), Gower Medical Publishing